Abstract
In summary, we found that PAI-1 4G/5G polymorphism is associated with the risk of malignant tumor development and we suggest that this polymorphism may contribute to an inherited predisposition to the development of malignancies; however further studies with larger series from diverse ethnic populations are needed to confirm our results.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 135-136 |
| Number of pages | 2 |
| Journal | Journal of B.U.ON. |
| Volume | 12 |
| Issue number | 1 |
| State | Published - Jan 2007 |
| Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]'. Together they form a unique fingerprint.
Cite this
Eroǧlu, A., Ulu, A., Çam, R., & Akar, N. (2007). Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients [2]. Journal of B.U.ON., 12(1), 135-136.